Sell: DexCom (DXCM)
From Cabot Growth Investor
Updated from Wall Street’s Best Investments 809, September 19, 2018
The market weakened further today, with growth stocks in particular hit hard, and now our Cabot Tides has turned negative, telling us the intermediate-term trend of the market is down.
Thus, risk minimization comes to the forefront, and in the Model Portfolio, that now means selling one more stock, DexCom (DXCM), which has seen some heavy volume selling this week, and is now well below its 50-day moving average.
Michael Cintolo, Cabot Growth Investor, www.cabotwealth.com, 978-745-5532, October 4, 2018